The chemosensitizing properties of iniparib in combination with gemcitabine (G) and carboplatin (C) in OVCAR-3 ovarian adenocarcinoma.
V. Ossovskaya
Employment or Leadership Position - BiPar Sciences
Consultant or Advisory Role - Sanofi
Stock Ownership - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
Expert Testimony - Sanofi
Other Remuneration - Sanofi
C. Lim
No relevant relationships to disclose
G. Schools
No relevant relationships to disclose
S. Kalurupalle
No relevant relationships to disclose
E. Broude
No relevant relationships to disclose
I. B. Roninson
No relevant relationships to disclose